New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For WLP;AET;UNH;HUM From The Last 14 Days
Check below for free stories on WLP;AET;UNH;HUM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2013
10:00 EDTAETOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:04 EDTAETAetna reinstated with a Buy at Goldman
Target $68.
May 20, 2013
16:31 EDTWLPWellpoint announces organizational realignment
Subscribe for More Information
09:47 EDTHUMHumana management to meet with JPMorgan
Subscribe for More Information
07:42 EDTUNHCohasset Associates to host a conference
National Conference on Managing Electronic Records is being held in Chicago on May 20-22.
May 16, 2013
10:10 EDTHUMQuest Diagnostics Humana acquires Concentra's laboratory business
Subscribe for More Information
May 15, 2013
17:36 EDTAETPaulson gives quarterly update on stakes
Subscribe for More Information
06:19 EDTWLPThree WellPoint directors resign, Bloomberg reports
Subscribe for More Information
May 14, 2013
12:00 EDTAETAetna forms strategic alliance with Tawuniya
Subscribe for More Information
10:01 EDTWLPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:43 EDTWLPWellpoint upgraded to Buy from Hold at Jefferies
Subscribe for More Information
May 13, 2013
17:51 EDTWLPWellpoint reaffirms FY13 EPS view of 'at least' $7.75, consensus $7.99
Subscribe for More Information
May 9, 2013
10:36 EDTWLPWellpoint volatility at low end of historic range
Subscribe for More Information
08:51 EDTHUMHumana appoints Roy A. Beveridge, M.D., as Chief Medical Officer
Humana (HUM) has appointed Roy A. Beveridge, M.D. as Senior VP and Chief Medical Officer, effective June 17. Dr. Beveridge is currently Chief Medical Officer for McKesson Specialty Health, a subsidiary of McKesson (MCK).
May 8, 2013
10:10 EDTHUMHumana announces plans to add 500 telesales positions
Subscribe for More Information
08:04 EDTAETAetna price target raised to $72 from $67 at Susquehanna
Susquehanna raised its price target on Aetna following the closing of its acquisition of Coventry Health as management anticipates earnings accretion to double over the next couple of years. Near-term the firm believes the company is well positioned to exceed its 2013 guidance. Shares are Positive rated.

Sign up for a free trial to see the rest of the stories you've been missing.